Cambrian BioPharma

Cambrian Bio | Catalyzing breakthroughs

New York, United States · Founded 2019 · $183.0M raised

Headquarters
New York, New York
Employees
11–50
Founded
2019
Business Model
B2B Biotech
Total Funding
$183.0M
Last Round
$23.0M Venture RoundJan 2025
Rounds
3

About

Cambrian Bio is a clinical-stage drug development company building medicines to treat and ultimately prevent age-related chronic diseases. The company partners with scientists to advance a portfolio of longevity-focused pipeline programs, leveraging repeatable development models to extend human healthspan.

Summary

Cambrian BioPharma is a Biotech company based in New York, United States, founded in 2019. It has raised $183.0M in total across 3 rounds, most recently a $23.0M Venture Round round in Jan 2025. Investors include Apollo and Alumni Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundJan 2025
$23.0M

Sign up to see all 3 rounds

Series B through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cambrian BioPharma on Indexed.vc
<a href="https://indexed.vc/companies/cambrian-biopharma"><img src="https://indexed.vc/api/badge/company/cambrian-biopharma" alt="Cambrian BioPharma on Indexed.vc" width="260" height="76" /></a>